Tag: LINC 2020

Disrupt PAD III

Sirolimus on the rise but paclitaxel “will probably come back again”

At this year’s Leipzig Interventional Course (LINC 2020; 28–31 January, Leipzig, Germany), William Gray (Main Line Health, Philadelphia, USA) considered the future of drug-coated...

LINC 2020: XTOSI study interim findings suggest “highly promising” safety and...

 Edward Choke (Singapore) talks to BLearning Peripheral at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the first-in-man clinical study—XTOSI—which looked at the safety and...

Paclitaxel mortality signal inconsistent across different geographies

While drug-coated balloons (DCBs) have been “consistently efficacious” across various studies, the mortality signal has not, Peter Schneider (University of California San Francisco, San...
Peter Schneider speaking with BLearning

LINC 2020: Geographical “inconsistencies” cast doubt on paclitaxel mortality signal

 Peter Schneider (San Francisco, USA) talks to BLearning Peripheral at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the relevance of dose relationship and geographical...
Paul Hayes 766x512

Real-time tissue perfusion device can assess re-establishment of blood flow to...

 Paul Hayes (Cambridge, UK) talks to BLearning Wounds at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the challenges of wound...
panos kitrou discusses drug-coated balloons central venous stenosis

Analysis of DCB use for treatment of central venous stenosis shows...

According to the findings of a European multicentre retrospective analysis, the use of drug-coated balloons (DCBs) for the treatment of symptomatic central venous stenosis...

LINC 2020: Profusa Lumee oxygen platform may improve clinical management of...

Profusa has announced research findings that suggest the company's Lumee oxygen platform may help improve the clinical management of patients with critical limb ischaemia...
WavelinQ & IN.PACT Adminal AV results released

LINC 2020: Positive new data for AV access interventions released

New arteriovenous (AV) access results were presented at the 2020 Leipzig Interventional Course (LINC; 28–31 January, Leipzig, Germany), including data on percutaneous AV fistula...
using clinical management of patientslumee-injector

LINC 2020: Profusa Lumee oxygen platform may improve clinical management of...

Profusa has announced research findings that suggest the company's Lumee oxygen platform may help improve the clinical management of patients with critical limb ischemia...
Panel at LINC Tuesday MEDTRONIC

LINC 2020: One year IN.PACT AV results show sustained patency benefit...

NOTE: This video is ONLY available to watch in selected countries and geographies  The one-year IN.PACT AV trial results, first presented at LINC 2020 (28–31 January, Leipzig,...

LINC 2020: High- and low-dose paclitaxel-coated balloons exhibit comparable results at...

At the 2020 Leipzig Interventional Course (28–31 January, Leipzig, Germany), Sabine Steiner (University of Leipzig, Leipzig, Germany) presented one-year results of the COMPARE-RTC of...

LINC 2020: BD announces long-term safety data for BTK drug-coated balloon

Today at the 2020 Leipzig Interventional Course (LINC; 28–31 January, Leipzig, Germany), BD announced that interim findings from the Lutonix below-the-knee (BTK) investigational...
ILLUMENATE

LINC 2020: Four-year ILLUMENATE data reaffirm safety profile of Stellarex

Philips today announced four-year results from the randomised controlled ILLUMENATE pivotal trial in the USA. The data show similar mortality rates through four years...